STAT+: FDA approves leucovorin for rare disorder without trial data

The FDA has approved leucovorin for a rare disorder without trial data. The news also covers Jeffrey Epstein's friend returning to biotech and investigations into the FDA's drug rejections, along with other biotech updates.